ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Movymia 250 μg/mL, Injektionslösung - 3
66818002 Spirig HealthCare AG
Movymia 250 μg/mL, Injektionslösung17.10.2018
  17.10.2018
Teriparatide (H05AA02) 
WHO-DDD 
07.99.3
07.99. 
B  
No 
IPCI
PR  
k.A.PR
  
7680668180028Biotechnologika
  
Composition
teriparatidum ADNr 250 µg, acidum aceticum glaciale, natrii acetas trihydricus, mannitolum, metacresolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.03 mg.
Packungsbestandteile
Injektionslösung 
  
 
Active AgentDose
Teriparatidum Adnr250 µg/ml
BAG: Active AgentDose
Teriparatidum Adnr250 mcg
 
Inactive agents
Acidum Aceticum Glaciale
Acidum Hydrochloridum ad Ph
Mannitolum
Metacresolum
Natrii Acetas Trihydricum
Natrii Hydroxidum ad Ph
 
Source
Data was imported : 07.08.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home